Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Baker Bros. Advisors LP | 6,062,702 10.900% | 2,199,463 (+56.93%) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 1,177,575 2.300% | -2,150,486 (-64.62%) | Filing History |
| 2022-04-11 11:14 am Purchase | 2022-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 5,065,113 10.060% | 2,261,778 (+80.68%) | Filing History |
| 2022-02-14 4:17 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | Baker Bros. Advisors LP | 3,863,239 7.700% | 1,548,366 (+66.89%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA CAPITAL MANAGEMENT L.P. | 4,871,067 9.700% | 692,000 (+16.56%) | Filing History |
| 2022-02-14 2:53 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 2,803,335 5.580% | 1,027,631 (+57.87%) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | James E. Flynn | 1,867,467 3.710% | -853,736 (-31.37%) | Filing History |
| 2022-02-10 5:02 pm Sale | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | JANUS HENDERSON GROUP PLC JHG | 3,133,935 6.200% | -1,357,830 (-30.23%) | Filing History |
| 2022-02-10 12:27 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | PRIMECAP MANAGEMENT CO/CA/ | 6,256,991 12.450% | 686,300 (+12.32%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BlackRock Inc. BLK | 3,328,061 6.600% | 596,955 (+21.86%) | Filing History |
| 2022-01-24 10:32 am Purchase | 2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | GOLDMAN SACHS GROUP INC GS | 3,057,559 6.100% | 3,057,559 (New Position) | Filing History |
| 2021-12-10 1:18 pm Sale | 2021-11-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | FEDERATED HERMES INC. FHI | 1,775,704 3.530% | -841,896 (-32.16%) | Filing History |